Cargando…

Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer Patients

INTRODUCTION: Survival rates in patients with non-medullary thyroid carcinoma (NMTC) are high, increasing the possibility to develop a second malignant neoplasm (SMN). Many studies investigated the relationship between increased risk of SMN in NMTC patients treated with radioiodine, but few data are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Capezzone, Marco, Sagnella, Alfonso, Cantara, Silvia, Fralassi, Noemi, Maino, Fabio, Forleo, Raffaella, Brilli, Lucia, Pilli, Tania, Cartocci, Alessandra, Castagna, Maria Grazia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931333/ https://www.ncbi.nlm.nih.gov/pubmed/35311228 http://dx.doi.org/10.3389/fendo.2022.845954

Ejemplares similares

The Combination of Sonographic Features and the Seven-Gene Panel May be Useful in the Management of Thyroid Nodules With Indeterminate Cytology
por: Capezzone, Marco, et al.
Publicado: (2021)

Improvement of Overall Survival Using TKIs as Salvage Therapy in Advanced Thyroid Carcinoma: Real-Life Data on a Single Center Experience
por: Brilli, Lucia, et al.
Publicado: (2021)

Familial non-medullary thyroid cancer: a critical review
por: Capezzone, M., et al.
Publicado: (2020)

Editorial: Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Clinical and Genetic Update
por: Valerio, Laura, et al.
Publicado: (2022)

Autosomal dominant familial neurohypophyseal diabetes insipidus caused by a novel missense mutation in AVP gene in a large Italian kindred
por: Marzocchi, Carlotta, et al.
Publicado: (2021)

Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer
por: Cantara, Silvia, et al.
Publicado: (2023)

Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis
por: Cantara, Silvia, et al.
Publicado: (2017)

Pregnancy-associated plasma protein A mRNA expression as a marker for differentiated thyroid cancer: results from a “surgical” and a “cytological” series
por: Marzocchi, C., et al.
Publicado: (2021)

PAPPA Expression in Indeterminate Thyroid Nodules as Screening Test to Select Patients for Molecular Testing
por: Marzocchi, Carlotta, et al.
Publicado: (2022)

Silent thyroiditis following vaccination against COVID-19: report of two cases
por: Capezzone, M., et al.
Publicado: (2022)

EIF1AX c.338-2A>T splice site mutation in a patient with trabecular adenoma and cytological indeterminate lesion
por: Castagna, Maria Grazia, et al.
Publicado: (2020)

From Circulating Tumor Cells to Mirna: New Challenges in the Diagnosis and Prognosis of Medullary Thyroid Cancer
por: Ricci, Claudia, et al.
Publicado: (2023)

CONUT Score: A New Tool for Predicting Prognosis in Patients with Advanced Thyroid Cancer Treated with TKI
por: Dalmiglio, Cristina, et al.
Publicado: (2022)

Effect of Pre-Existent Sarcopenia on Oncological Outcome of Advanced Thyroid Cancer Patients Treated with Tyrosine Kinase Inhibitors
por: Dalmiglio, Cristina, et al.
Publicado: (2022)

Nodular Thyroid Disease in the Era of Precision Medicine
por: Tumino, Dario, et al.
Publicado: (2020)

Telomeres and Thyroid Cancer
por: Capezzone, Marco, et al.
Publicado: (2009)

Dynamic Risk Stratification Integrated with ATA Risk System for Predicting Long-Term Outcome in Papillary Thyroid Cancer
por: Valerio, Laura, et al.
Publicado: (2023)

Update on Targeted Therapy in Medullary Thyroid Cancer
por: Okafor, Christian, et al.
Publicado: (2021)

Thirty synchronous medullary and papillary thyroid carcinomas
por: Zhang, Daqi, et al.
Publicado: (2023)

Oncologic outcomes of calcitonin-negative medullary thyroid carcinoma
por: Yue, Wenliang, et al.
Publicado: (2022)

Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy
por: Brilli, L., et al.
Publicado: (2020)

Permanent diabetes insipidus in a patient with mesothelioma treated with immunotherapy
por: Brilli, Lucia, et al.
Publicado: (2020)

IGF-I Influences Everolimus Activity in Medullary Thyroid Carcinoma
por: Gentilin, Erica, et al.
Publicado: (2015)

Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine
por: Matrone, Antonio, et al.
Publicado: (2022)

The Prediction of Metastases of Lateral Cervical Lymph Node in Medullary Thyroid Carcinoma
por: Zhou, Tian-Han, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?
por: Di Molfetta, Sergio, et al.
Publicado: (2021)

Unilateral Surgery for Medullary Thyroid Carcinoma: Seeking for Clinical Practice Guidelines
por: Zhang, Daqi, et al.
Publicado: (2022)

Proteasome inhibitors in medullary thyroid carcinoma: time to restart with clinical trials?
por: Fanciulli, Giuseppe, et al.
Publicado: (2023)

What is the status of immunotherapy in thyroid neoplasms?
por: Garcia-Alvarez, Alejandro, et al.
Publicado: (2022)

A Benign Medullary Thyroid Cancer
por: Pishdad, Reza, et al.
Publicado: (2022)

Serum miR-375 for Diagnostic and Prognostic Purposes in Medullary Thyroid Carcinoma
por: Censi, Simona, et al.
Publicado: (2021)

Basal and Calcium-Stimulated Procalcitonin for the Diagnosis of Medullary Thyroid Cancers: Lights and Shadows
por: Censi, Simona, et al.
Publicado: (2021)

Educational Case: Endocrine Neoplasm: Medullary Thyroid Carcinoma
por: Segura, Sheila, et al.
Publicado: (2018)

Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer
por: Cantara, Silvia, et al.
Publicado: (2010)

Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma
por: Park, Hyunju, et al.
Publicado: (2021)

Prognostic Impact of Inflammatory Markers PLR, LMR, PDW, MPV in Medullary Thyroid Carcinoma
por: Li, Canxiao, et al.
Publicado: (2022)

Proteotypic Differences of Follicular-Patterned Thyroid Neoplasms
por: Huang, Dongdong, et al.
Publicado: (2022)

Immunohistochemistry in the pathologic diagnosis and management of thyroid neoplasms
por: Crescenzi, Anna, et al.
Publicado: (2023)

Clinical and Genetic Features of a Large Monocentric Series of Familial Non-Medullary Thyroid Cancers
por: Cirello, Valentina, et al.
Publicado: (2021)

Validation of miRNAs as diagnostic and prognostic biomarkers, and possible therapeutic targets in medullary thyroid cancers
por: Mondin, Alberto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qg4lupub8dtfk6m6bbnp760q5k